Advertisement
Loading...

ArriVent BioPharma, Inc. Common Stock

AVBP•NASDAQ
Healthcare
Biotechnology
$26.73
$-0.27(-1.00%)
U.S. Market opens in 1h 37m
Advertisement

ArriVent BioPharma, Inc. Common Stock (AVBP) Stock Overview

Explore ArriVent BioPharma, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-8.29
EPS (TTM)$-3.38
ROE-0.49%
Fundamental Analysis

AI Price Forecasts

1 Month$18.19
3 Months$14.52
1 Year Target$14.80

AVBP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ArriVent BioPharma, Inc. Common Stock (AVBP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.29 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.00%
5-Day Change
2.22%
1-Month Change
-12.13%
3-Month Change
14.77%
6-Month Change
17.34%
Year-to-Date (YTD) Change
32.85%
1-Year Change
29.57%
3-Year Change
33.65%
5-Year Change
33.65%
All-Time (Max) Change
33.65%

Contact Information

https://www.arrivent.com
628-277-4836
18 Campus Boulevard, Newtown Square, NaN, 19073

Company Facts

52 Employees
IPO DateJan 26, 2024
CountryUS
Actively Trading

Frequently Asked Questions